Sign Out
A moderate amount of data on pregnant women (between 300-1000 pregnancy outcomes) indicate no malformative or feto/neonatal toxicity of Pantoprazole (Pantoloc).
Animal studies have shown reproductive toxicity.
As a precautionary measure, it is preferable to avoid the use of Pantoprazole (Pantoloc) during pregnancy.
Animal studies have shown excretion of pantoprazole in breast milk. There is insufficient information on the excretion of pantoprazole in human milk but excretion into human milk has been reported. A risk to the newborns/infants cannot be excluded. Therefore, a decision on whether to discontinue breast-feeding or to discontinue/abstain from Pantoprazole (Pantoloc) therapy should take into account the benefit of breast-feeding for the child, and the benefit of Pantoprazole (Pantoloc) therapy for the woman.
There was no evidence of impaired fertility following the administration of pantoprazole in animal studies.
Continue with Google